Senzime AB has secured a new contract to supply its anesthesia monitoring technology to a hospital for pediatric care and released clinical data regarding the performance of its TetraGraph system. The agreement expands the company’s presence in the pediatric anesthesia market, while the newly published findings detail the system’s clinical outcomes in young patients.
The contract mandates the implementation of the TetraGraph monitoring system, which tracks neuromuscular blockade in patients undergoing surgery. According to the company’s report, the clinical data highlights the system’s efficacy in pediatric settings, specifically focusing on the precision of monitoring muscle relaxation during anesthesia. Senzime officials stated that these results demonstrate the system’s utility in managing anesthesia levels for pediatric populations, where precise dosing remains a clinical priority. The company intends to use this data to support further adoption of its monitoring technology across additional healthcare facilities.
Newsflash | Powered by GeneOnline AI
Source: GO-AI-ne1
For any suggestion and feedback, please contact us.
Date: June 3, 2026
發佈留言